Sign in

CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company

PALISADE BIO, INC.

Sign in to watch
Ticker
PALI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522007292
Phone
(858) 704-4900
Business address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Former names
PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $2.44 ($4,880)
  5. 4 Open-market buy Chief Executive Officer bought 6,000 shares at $2.49 ($14,940)
  6. 4 Open-market buy Director bought 14,999 shares at an average $2.82 ($42,297)
  7. 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $2.65 ($26,468)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award Director acquired 304,479 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Chief Executive Officer acquired 1,592 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 28,718 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 7 of 18 · 343 filings